🇺🇸 FDA
Patent

US 11786591

Recombinant metapneumovirus F proteins and their use

granted A61KA61K39/155A61K39/39

Quick answer

US patent 11786591 (Recombinant metapneumovirus F proteins and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61K, A61K39/155, A61K39/39, A61K48/00